Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence

Overview of attention for article published in Breast Cancer Research, September 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 5 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 31 Dimensions

Readers on

mendeley: 60 Mendeley

Summary X Facebook Dimensions citations

So far, Dimensions has found 31 publications that cite this research output.

31

The most recent citing publications are shown below. View all 31 publications that cite this research output on Dimensions.

Effects of Selective and Nonselective Beta Blockers on Bone Mineral Density in Mexican Patients with Breast Cancer

Article in Cancers (August 2024)

Benefit of adjuvant bisphosphonates in early breast cancer treated with contemporary systemic therapy: A meta-analysis of randomized control trials

Article in Heliyon (January 2024)

Novel Synergistic Combination of Pamidronate and Temozolomide for Breast Cancer Therapeutics

Article in Current Cancer Drug Targets (January 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.